IP Library Assignment 022813/0195
Patent Assignment
Reel/Frame 022813/0195

Patent and Trademark Security Agreement

Recorded: 2009-06-11 Received: 2009-06-11 Pages: 67
Assignor
Assignee
J.P. MORGAN CHASE BANK, N.A., TORONTO BRANCH, AS ADMINISTRATIVE AGENT
200 BAY STREET, SUITE 1800, TORONTO, CAX, M5J 2J2, CANADA
Covered Properties (30)
Pharmaceutical Compositions
Application: 12/360,673 →
Controlled Release Dosage Forms
Application: 12/328,828 →
Controlled Release Dosage Forms
Application: 12/169,852 →
Modified-Release Formulations of a Bupropion Salt
Application: 11/993,723 →
Chronotherapeutic Diltiazem Formulations and the Administration Thereof
Application: 11/952,343 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/930,644 →
Modified Release Formulations of at Least One Form of Tramadol
Application: 11/928,908 →
Bupropion Hydrobromide and Therapeutic Applications
Application: 11/834,848 →
Modified Release Formulations of a Bupropion Salt
Application: 11/774,109 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,213 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,251 →
Modified Release Formulations of a Bupropion Salt
Application: 11/766,239 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,820 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,840 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,368 →
Modified Release Formulations of a Bupropion Salt
Application: 11/762,343 →
Modified Release Formulations of a Bupropion Salt
Application: 11/759,413 →
Modified Release Formulations Of Selective Serotonin Re-Uptake Inhibitors
Application: 10/556,492 →
Modified Release Formulations of a Bupropion Salt
Application: 11/755,946 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,768 →
Modified Release Formulations of a Bupropion Salt
Application: 11/751,785 →
Modified Release Formulations of a Bupropion Salt
Application: 11/475,252 →
Modified Release Tablet of Bupropion Hydrochloride
Application: 11/451,496 →
Modified release formulations of at least one form of tramadol
Application: 10/517,809 →
Modified Release Compositions of at Least One Form of Tramadol
Application: 10/933,479 →
Extended release pharmaceutical tablet of metformin
Application: 10/771,987 →
Chronotherapeutic Diltiazem Formulations and the Administration Thereof
Application: 10/657,752 →
Controlled Release Dosage Forms
Application: 10/370,109 →
Extended release pharmaceutical tablet of metformin
Application: 10/309,193 →
Extended Release Metformin Hydrochloride Formulations
Application: 09/845,496 →